SCHEMBL14633160

SCHEMBL14633160

CN1CCN(c2ccc(Nc3ncc4c(=O)n(-c5c(Cl)cncc5Cl)nc(-c5cncs5)c4n3)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 11/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ PAK1 Q13153 3/20 0.52
▸ PAK3 O75914 2/20 0.52
▸ PAK2 Q13177 2/20 0.52
▸ PKN1 Q16512 1/20 0.52
▸ KCNH2 Q12809 1/20 0.49
▸ ALK Q9UM73 1/20 0.45
▸ SRC P12931 3/20 0.44
▸ LCK P06239 2/20 0.44
▸ KDR P35968 2/20 0.44
▸ CDK2 P24941 2/20 0.44
▸ FGFR1 P11362 1/20 0.44
▸ FGFR2 P21802 1/20 0.44
▸ FGFR4 P22455 1/20 0.44
▸ FGFR3 P22607 1/20 0.44
▸ IGF1R P08069 1/20 0.44
▸ DYRK1B Q9Y463 1/20 0.44
▸ CCNK O75909 1/20 0.42
▸ CCNA2 P20248 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14632811 0.95 WEE1 (0.61) WEE1CYP3A4PAK1PAK3PAK2
SCHEMBL14633151 0.86 WEE1 (0.56) WEE1CYP3A4KCNH2ALKSRC
SCHEMBL14632865 0.85 WEE1 (0.57) WEE1CYP3A4KCNH2CDK2CCNA2
SCHEMBL14633280 0.85 WEE1 (0.63) WEE1CYP3A4KCNH2ALKSRC
SCHEMBL14633231 0.84 WEE1 (0.56) WEE1CYP3A4KCNH2ALKSRC
SCHEMBL14632797 0.84 WEE1 (0.56) WEE1CYP3A4KCNH2ALKSRC
SCHEMBL14633298 0.82 WEE1 (0.63) WEE1CYP3A4KCNH2ALKSRC
SCHEMBL14633357 0.81 WEE1 (0.62) WEE1CYP3A4KCNH2SRCLCK
SCHEMBL14633445 0.81 WEE1 (0.64) WEE1CYP3A4KCNH2ALKSRC
SCHEMBL14632958 0.81 WEE1 (0.66) WEE1CYP3A4KCNH2ALKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US claimed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO claimed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US claimed
US-9051327-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2015-06-09 — — US disclosed
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBVIE INC (US) 2014-10-02 — — US disclosed
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US disclosed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO disclosed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CYP3A4 1925/4885PAK1 71/4885
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CYP3A4 1925/4885PAK1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback